Alzheimer's disease is a progressive neurodegenerative Rivastigmine Transdermal Patch disorder that significantly impacts cognitive function. Current treatment options often provide only symptomatic relief, addressing the effects of the disease without targeting its underlying causes. Rivastigmine transdermal patch presents a promising approach to